Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) (344139)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

The Avenir Award supports early-stage investigators embarking on highly innovative studies. It focuses on aiding those at the beginning of their careers who may not have the preliminary data for an R01 grant but propose impactful research and demonstrate potential as future leaders. NIDA has initiated two Avenir Award Programs for research in HIV/AIDS and in genetics or epigenetics. Each application may request up to $300,000 in Direct Costs annually for a maximum of five years, in addition to applicable Facilities and Administrative (F&A) costs.

Eligibility

Organization's Location
ullamco ad
Program Location
sunt
Organization Type
up to 1.5M

Submission

Schedule
Step 1: labore dolore proident
Application deadline
Nov 13, 2024
Step 2: ut ad (exercitation et)

Similar grants